Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Sarcoma, Alveolar Soft Part 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Lymphoma 1Endometrial Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1

Interventions

Irinotecan 4Octreotide 3Probiotics 2Leucovorin 2Fluorouracil 2shosaiko-to 1maltodextrin 1lanreotide 1isatuximab 1bile acid binding proteins 1Temozolomide 1Sulfasalazine 1Raloxifene Hydrochloride 1Radiation 1Oxaliplatin 1Loperamide 1Long-Term Synaptic Depression 1Levofloxacin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Diet Therapy 1Cyclophosphamide 1Colesevelam Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1Calcium Aluminosilicate 1Anti-Bacterial Agents 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diarrhea × Loperamide × Clear all
NCT00003057 2023-06-18

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
500 enrolled
Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡